ARMP - Armata Pharmaceuticals, Inc.

QQQ $ 455.25 $ 5.77 (1.29 %)

DIA $ 409.08 $ 4.58 (1.13 %)

SPY $ 546.60 $ 6.05 (1.12 %)

TLT $ 99.96 $ 0.43 (0.43 %)

GLD $ 231.58 $ 0.97 (0.42 %)

Previous Close

$ 2.3

Open

Bid

$ 2.42 x 100

Ask

-- x --

Day's Range

-- - --

52 Week Range

$ 1.90 - $ 4.48

Volume

8,402

Average Volume

Market Cap

83.22M

Beta (5Y Monthly)

$ 0.79

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-13-2024	06-30-2024	10-Q
2	05-07-2024	03-31-2024	10-Q
3	03-21-2024	12-31-2023	10-K
4	08-14-2023	06-30-2023	10-Q
5	05-11-2023	03-31-2023	10-Q
6	03-16-2023	12-31-2022	10-K
7	11-09-2022	09-30-2022	10-Q
8	08-11-2022	06-30-2022	10-Q
9	05-12-2022	03-31-2022	10-Q
10	03-17-2022	12-31-2021	10-K
11	11-10-2021	09-30-2021	10-Q
12	08-12-2021	06-30-2021	10-Q
13	05-13-2021	03-31-2021	10-Q
14	03-18-2021	12-31-2020	10-K
15	11-12-2020	09-30-2020	10-Q
16	08-13-2020	06-30-2020	10-Q
17	05-14-2020	03-31-2020	10-Q
18	03-19-2020	12-31-2019	10-K
19	11-12-2019	09-30-2019	10-Q
20	08-14-2019	06-30-2019	10-Q
21	05-06-2019	03-31-2019	10-Q
22	03-25-2019	12-31-2018	10-K
23	11-08-2018	09-30-2018	10-Q
24	08-09-2018	06-30-2018	10-Q
25	05-15-2018	03-31-2018	10-Q
26	03-14-2018	12-31-2017	10-K
27	11-14-2017	09-30-2017	10-Q
28	08-14-2017	06-30-2017	10-Q
29	05-15-2017	03-31-2017	10-Q
30	03-27-2017	12-31-2016	10-K
31	11-10-2016	09-30-2016	10-Q
32	08-15-2016	06-30-2016	10-Q
33	05-12-2016	03-31-2016	10-Q
34	03-30-2016	12-31-2015	10-K
35	11-16-2015	09-30-2015	10-Q
36	08-13-2015	06-30-2015	10-Q
37	05-15-2015	03-31-2015	10-Q
38	04-15-2015	12-31-2014	10-K
39	11-14-2014	09-30-2014	10-Q
40	09-12-2014	06-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Armata Pharmaceuticals Appoints David Hou...
08/15/2024 20:46:39

Armata Pharmaceuticals, Inc. (NYSE:ARMP) ("Armata" or the "Company"), a biotechnology company focused on the de...

HC Wainwright & Co. Reiterates Buy on Arma...
08/15/2024 10:18:54

HC Wainwright & Co. analyst Joseph Pantginis reiterates Armata Pharmaceuticals (AMEX:ARMP) with a Buy and maintains $7 p...

Armata Pharmaceuticals Q2 2024 GAAP EPS $(...
08/13/2024 20:46:29

Armata Pharmaceuticals (AMEX:ARMP) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of ...

Armata Pharmaceuticals Has Received Additi...
07/30/2024 11:16:01

HC Wainwright & Co. Reiterates Buy on Arma...
07/11/2024 13:43:01

HC Wainwright & Co. analyst Joseph Pantginis reiterates Armata Pharmaceuticals (AMEX:ARMP) with a Buy and maintains $7 p...

Armata Pharmaceuticals Achieved Full Enrol...
07/11/2024 11:09:07

Armata Pharmaceuticals To Present Viruses ...
07/10/2024 20:09:35

HC Wainwright & Co. Reiterates Buy on Arma...
05/08/2024 13:35:03

HC Wainwright & Co. analyst Joseph Pantginis reiterates Armata Pharmaceuticals (AMEX:ARMP) with a Buy and maintains $7 p...

Armata Pharmaceuticals Q1 EPS $(0.69) Miss...
05/07/2024 20:41:10

Armata Pharmaceuticals (AMEX:ARMP) reported quarterly losses of $(0.69) per share which missed the analyst consensus estimate o...

HC Wainwright & Co. Maintains Buy on Armat...
03/22/2024 14:58:52

HC Wainwright & Co. analyst Joseph Pantginis maintains Armata Pharmaceuticals (AMEX:ARMP) with a Buy and maintains $7 pr...

Armata Pharmaceuticals Q4 EPS $(0.55) Miss...
03/21/2024 20:07:48

Armata Pharmaceuticals (AMEX:ARMP) reported quarterly losses of $(0.55) per share which missed the analyst consensus estimate o...

Armata Pharmaceuticals Enters Secured Cred...
03/04/2024 21:03:01

The gross proceeds to be received by the Company at closing are $35 million before deducting transaction-related expenses. Proc...

12-health-care-stocks-moving-in-wednesdays-intraday-session

12 Health Care Stocks Moving In Wednesday'...
01/10/2024 17:31:03

Armata Pharmaceuticals Q3 EPS $(0.86) Miss...
11/14/2023 21:05:24

Armata Pharmaceuticals (AMEX:ARMP) reported quarterly losses of $(0.86) per share which missed the analyst consensus estimate o...

Armata Pharmaceuticals Announces Presentat...
10/30/2023 12:07:59

Armata Pharmaceuticals Has Dosed The First...
09/26/2023 12:13:47

12-health-care-stocks-moving-in-tuesdays-intraday-session

12 Health Care Stocks Moving In Tuesday's ...
08/22/2023 17:31:17

HC Wainwright & Co. Reiterates Buy on Arma...
08/14/2023 15:09:55

HC Wainwright & Co. analyst Joseph Pantginis reiterates Armata Pharmaceuticals (AMEX:ARMP) with a Buy and maintains $7 p...

12-health-care-stocks-moving-in-thursdays-intraday-session

12 Health Care Stocks Moving In Thursday's...
07/27/2023 17:31:04

Why Universal Health Services Shares Are T...
07/26/2023 17:57:17

Gainers Silicon Motion Technology Corporation (NASDAQ: SIMO) shares climbed 78.9% to $93.40 following a report suggesting C...